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rEffect of Physician and Hospital Experience on Patient Outcomes for
Endovascular Treatment of Aortoiliac Occlusive Disease
Indes JE, Tuggle CT, Madawat A, et al. Arch Surg 2011;146:966-71.
Conclusion: Hospital and physician volume are predictors of patient
outcome after endovascular treatment of aortoiliac occlusive disease
(AIOD).
Summary: Patients undergoing some vascular and cancer procedures
have a decreased risk of operative death when the procedures are performed
in high-volume hospitals. For many procedures, associations between mor-
tality and hospital volume aremediated through surgeon volume (Birkmeyer
JD et al, N Engl J Med 2002;346:1128-37). Little information is available
on the relationship between physician volume, hospital volume, and the
outcomes of endovascular procedures for AOID. In the study reported here,
the authors evaluated the effects of physician volume, and especially in-
hospital volume, on outcomes of endovascular repair in patients with AIOD.
This was a retrospective, cross-sectional analysis, of in-patients undergoing
endovascular repair of AIOD. Physicians were considered low volume if they
performed 17 procedures per year or high volume if they performed 17
procedures per year. Hospital volume was defined as high (116 procedures
per year) and low (116 procedures per year). The authors identified 818
in-patients who underwent endovascular repair of AIOD from the Health-
care Cost and Utilization Project Nationwide In-patient Sample from Jan-
uary 2003 through December 2007. The main outcome measures were
in-hospital complications and mortality, length of stay, and cost. Of the 818
procedures, 59% were of high-volume physicians who were surgeons, and
65% practiced at high-volume hospitals. Complication rates (unadjusted)
were higher for low-volume compared with high-volume physicians (18.7%
vs 12.6%: P  .02). However, complication rates were not affected by
physician’s specialty or hospital volume. Length of stay was shorter for
patients of high-volume physicians (P  .001), hospitals (P  .001), and
surgeon providers (P  .03). Physician specialty was also associated with
decreased cost (P .004). With multivariate analysis, high physician volume
was associated with lower complications (P  .04), high hospital volume
with shorter length of stay (P  .002), and nonsurgeons with higher costs
(P  .05).
Comment: There are many problems with this report. First, the study
only looked at in-patients; however, the very large majority of patients
undergoing endovascular interventions for AIOD are treated as out-
patients. In addition, this study did not look at the appropriateness of inter-
ventions. High-volume specialists are sometimes associated with a higher
volume of marginal or inappropriate procedures. The study likely represents
a highly skewed sample of patients undergoing endovascular treatment for
AIOD for unclear indications. It is not possible to do a drill down with this
data to determine why shorter lengths of stay might be associated with
higher-volume physicians or why surgeons were associated with lower
hospital costs. It is certainly possible that patients and their risk factors or
complexity of procedure might not have been stratified equally among the
providers and the hospitals. Overall, this article really provides actually little
insight about the relationship between physician and hospital volume for
endovascular treatment of patients with AIOD.
Heart Disease May Be a Risk Factor for Pulmonary EmbolismWithout
Peripheral Deep Venous Thrombosis
Sorensen HT, Horvath-Phuo E, Lash TL, et al. Circulation 2011;124:
1435-41.
Conclusion: Heart disease increases the risk of pulmonary embolism
(PE) not associated with diagnosed deep venous thrombosis (DVT).
Summary: Up to 40% of patients with PE do not have evidence of
DVT (Hull RD, et al, Ann Intern Med 1983;98:91-99). A possible expla-
nation is that the emboli were dislodged from the lower extremity and are
now in the lungs. An additional explanation is that the emboli may come
from another embolic source, including the heart. This may be especially
true in the setting of cardiac disease. Left-sided cardiac thrombi predispose
to arterial embolization. Autopsy series have shown, however, that right-
sided intercardiac thrombosis may be as common as thrombosis on the left
(Ögren M, Eur Heart J 2005;26:1108-14). Echocardiographic studies have
reported right-sided cardiac thrombi in patients with acute PE (Goldhaber
SZ, et al, Mayo Clin Proc 1988;63:1261-4). Recently, it has also been
suggested that there is a higher prevalence of heart disease in patients with
PE and no detected DVT compared with patients who have PE and DVT
(Prandoni P, et al, Eur J Intern Med 2009;20:470-3).The authors sought to determine if cardiac risk factors that increase the
risk of left-sided atrial embolismmay also be associated with an increased risk
o
ef PE without apparent DVT, thereby implicating the heart itself as a
otential source of PE. This was a nationwide, population-based, case-
ontrolled study in Denmark of patients who had a diagnosis of PE or DVT,
r both, between 1980 and 2007. Odds ratios were computed to estimate
elative risk and associated preceding heart disease with PE, PE and DVT, or
VT alone. There were 45,282 patients with PE alone: 4680 with PE and
VT, and 59,790 withDVT alone. An additional 541,561 patients served as
opulation controls. Data indicated that myocardial infarction and heart
ailure in the 3 months before PE conferred a higher risk of apparently
solated PE (OR, 43.5 [95% CI, 39.6-47.8] and 32.4 [29.8-35.2], respec-
ively). The risk of combined PE and DVT (OR 19.7 [95% CI, 16.0-24.2]
nd OR, 22.1 [18.7-26.0] respectively), and DVT alone (OR, 9.6 [8.6-
0.7] and 12.7 [11.6-13.9]) were lower. The OR for left-sided valvular
isease was 13.5 (95% CI, 11.3-16.1). However, the OR for right-sided
alvular disease was 74.6 (95% CI, 28.4-195.8).
Comment: The proportion of apparently isolated PE is much higher in
his study than one would expect. The authors did not have data on how
ften the presence of DVT was assessed in patients with PE. However,
ultiple studies have indicated not everyone with PE has a diagnosable
VT. The authors’ observations on the timing of PE in relationship to
ardiac disease, previous studies indicating a significant prevalence of right-
ided cardiac thrombi, and the strong ORs in this study implicating right-
ided cardiac sources for PE, all combine to suggest the right heart can serve
s a source of PE. A similar analysis performed in patients with PE simulta-
eously assessed for cardiac disease and DVT is needed to determine the
roportion of PEs that originate from the right heart.
ntracranial Hemorrhage IsMuchMore Common After Carotid Stent-
ng Then After Endarterectomy: Evidence From the National Inpatient
ample
cDonald RJ, Cloft HJ, Kallmes DF. Stroke 2011;42:2782-7.
Conclusion: Patients undergoing carotid artery stenting (CAS) are
ore likely to experience intracranial hemorrhage (ICH), in-hospital death,
nd unfavorable discharges relative to those undergoing carotid endarterec-
omy (CEA).
Summary: ICH after carotid revascularization occurs after 0.2% to
.5% of patients (van Mook WN, et al, Lancet Neurol 2005;4:877-88).
ittle data, if any, are available to determine if ICH rates vary between
pecific revascularization procedures. Even large studies, such as CREST,
ack sufficient power to study relative rates of infrequent complications such
s ICH. The National Inpatient Sample (NIS) is a sufficiently large database
o investigate infrequent complications. It provides information with respect
o20% of nonfederal hospitalizations in the United States. This represents
8 million annual hospitalizations (http://www.HCUP-US.AHRQ.
OV/databases.jsp). The authors used the NIS to determine prevalence of,
ype of, and risk factors associated with ICH among recipients of CAS and
EA.
Cases of ICH after CEA or CAS were retrieved from the NIS from 2001
o2008.Clinical presentation (asymptomatic vs symptomatic), discharge status,
n-hospital mortality, demographics, and hospital characteristics were extracted
rom NIS data. ICD-9 and clinical classification software codes were used to
etermine Charlson indices of comorbidity. Multivariate regression analysis
etermined the effect of revascularization procedure type and symptom status
n ICH, in-hospital mortality, and an unfavorable discharge, defined as those
equiring skilled care (short-term hospitalization, skilled nursing facility, home
ealth care).
Among the 57,663,483 NIS hospital admissions were 215,012 CEAs
nd 13,884 CAS procedures. Only 10,049 CEA cases (5%) were considered
ymptomatic, and only 1,251 CAS cases (10%) were for symptomatic
isease. ICH occurred more frequently after CAS than CEA in both symp-
omatic (4.4% vs 0.8%; P .0001) and asymptomatic presentations (0.5% vs
.6%; P  .0001). Multivariate regression indicated that symptomatic
resentation and CAS procedures were independently predictive of a sixfold
o sevenfold increase frequency of postoperative ICH. ICH was in turn
ndependently predictive of a 30-fold increased risk of death before dis-
harge. Among symptomatic patients treated with CAS who developed
CH, the risk for ICH was higher in younger patients.
Comment: The NIS data do not allow independent diagnosis of
yperperfusion among cases of ICHor if hyperperfusion wasmost predictive
f ICH. NIS also contains coding errors, but arguably, such errors occur at
andom so that the data are not biased for or against one procedure or the
ther. The overall dramatic relative increase in ICH in CAS vs CEA patients,
specially those who are symptomatic, is another bit of data arguing for
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